
Embecta Corp.: financial statements
Price
$6.25
November 16, 2026Market cap $366M
What Ploutos Investor adds for Embecta
Part of Ploutos Investor, €9.99 a month
- The full history: 6 fiscal years, from FY2020
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has risen 46% since Aug 7, 2026, when the 10-Q these figures come from was filed ($4.42 then, $6.46 on Nov 13, 2026). The figures date from before that move.10-Q
- The company lowered its dividend in the past year. The trailing yield still counts the higher payments before the cut.
- The latest annual figures the company filed are for 2025, more than a year ago. Newer ones may be late.
Financial statements
Each fiscal year's income statement, balance sheet and cash flow as the company filed them, and the latest quarters.
Click a line to see it on the chart.
Revenue
-1.8% a year over 2 years
| Line | FY2023 | FY2024 | FY2025 | Average a year |
|---|---|---|---|---|
| Revenue | $1.1B | $1.1B | $1.1B | -1.8% |
| Cost of revenue | $371M | $388M | $404M | +4.3% |
| Gross profit | $750M | $735M | $677M | -5.0% |
| Operating income | $222M | $167M | $242M | +4.5% |
| Net income | $70M | $78M | $95M | +16.4% |
| Earnings per share | $1.22 | $1.34 | $1.62 | +15.2% |
| Earnings per share, basic | $1.23 | $1.36 | $1.64 | +15.5% |
| Margins | ||||
| Gross margin | 66.9% | 65.5% | 62.6% | |
| Operating margin | 19.8% | 14.9% | 22.4% | |
| Net margin | 6.3% | 7.0% | 8.8% | |
Financial statements
EMBC's revenue, profits and cash flows from FY2020 to FY2022, 3 more fiscal years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 5 fiscal years.
By segment
Revenue and operating income by business segment or by product, as the company itself reports them in each year's 10-K. Each year from the latest filing that carries it, so a segment renamed or re-cut shows in its current form.
- Pen Needles
- Syringes
- Manufacturing Facility
- Product And Service Other
- Safety
- FY2023: Pen Needles $829M, Syringes –, Manufacturing Facility $13M, Product And Service Other $14M, Safety $126M
- FY2024: Pen Needles $844M, Syringes $126M, Manufacturing Facility $13M, Product And Service Other $10M, Safety $129M
- FY2025: Pen Needles $784M, Syringes $125M, Manufacturing Facility $20M, Product And Service Other $14M, Safety –
| Product | FY2023 | FY2024 | FY2025 | Share FY2025 |
|---|---|---|---|---|
| Pen Needles | $829M | $844M | $784M | 83% |
| Syringes | – | $126M | $125M | 13% |
| Manufacturing Facility | $13M | $13M | $20M | 2.1% |
| Product And Service Other | $14M | $10M | $14M | 1.5% |
By segment
EMBC's revenue by product line from FY2022 to FY2022, 1 more fiscal year
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 4 fiscal years.
From the XBRL of 5 of the company's annual reports to the SEC (ASC 280). Amounts in dollars.
Amounts are in dollars as the company filed them in its annual reports (10-K or 20-F). Those reporting in another currency are converted at each fiscal year-end rate. Shares and earnings per share are adjusted for splits.
Debt and obligations
What the company owes beyond the loans on its balance sheet, and when it pays, from the notes to its annual report: debt maturities, leases, pension plans, goodwill by segment, and how it gets to the tax it pays.
When the debt falls due
Sep 30, 2025Due within 2 years
$19M
Principal of loans and bonds falling due, from the annual report dated September 30, 2025, without leases and interest. The filing
- 9/2026: $9.5M
- 9/2027: $9.5M
Leases
Sep 30, 2025Operating leases
$17M
Finance leases
$32M
The liability is the present value of the rent still to pay, at September 30, 2025. It is not counted in the ladder's debt. The filing
Goodwill by segment
Sep 30, 2025Total goodwill
$15M
The company does not state its goodwill by segment, at September 30, 2025. The filing
From the statutory to the effective tax rate, FY2025
Sep 30, 2025Statutory rate
21.0%
Effective rate
30.0%
The company paid 30.0% in tax on its profit, 9.0 points above the US federal rate (21.0%). Below, the reasons it gives.
The lines the company states do not reach its effective rate, so we do not show them. Both rates are the filing's. The filing
Earnings quality
How the reported earnings were made, read from the filings. A description, not a score: our tests found no link between these measures and later share returns.
Where the change in earnings per share came from
Diluted earnings per share went from $1.34 in the fiscal year to Sep 30, 2024 to $1.62 in the year to Sep 30, 2025, a change of +$0.28.
Measured by size, 51.3% of the movement came from outside sales and operating margin: interest and other items, the tax rate, what went to others and the share count.
- -$0.16
- +$1.76
- +$0.35
- -$1.66
- -$0.02
Earnings per share is split as sales times operating margin, plus interest and other items, after tax, times the part that goes to the common shareholders, divided by the diluted share count. Each source's part is its average effect over every order in which the six can change, so the parts add up exactly to the change. From the annual reports; net income over the diluted count matches the earnings per share the company filed within 2%.
Receivables and inventory against sales
In the quarter to Jun 30, 2026, sales were -8.1% on the same quarter a year earlier, and receivables -0.3%. Inventory was +12.8%, against +20.3% for the cost of sales.
- a year earlier 56 days
- 60 days
- a year earlier 174 days
- 163 days
Balances at Jun 30, 2026 and Jun 30, 2025, against the sales and cost of sales of the quarter ending on each date; a fourth quarter is the fiscal year less its first nine months. Same quarter against same quarter, so the season is the same.
Allowance for doubtful accounts
The allowance for receivables that may not be collected was 1.4% of gross receivables at Jun 30, 2026, against 1.1% a year earlier.
- a year earlier $2.0M
- $2.6M
Taxes: deferred and paid
The deferred part was 43.0% of the tax charge in the year to Sep 30, 2025.
Cash taxes paid were 215.0% of the current tax charge in the year to Sep 30, 2025.
- Deferred share, year to Sep 30, 2025$18M of $41M
- 43.0%
- $50M paid, $23M current
- 215.0%
When profit in the accounts runs ahead of taxable profit, the deferred part grows. It also moves for reasons unrelated to how earnings are booked: tax-law changes, the use of past losses, and the US rule since 2022 that spreads research costs over five years. Where the notes report it, the tax-rate bridge under Debt and obligations shows how the rate gets from the statutory one to the effective one.
A reading is called out when it is above the 90th percentile of the same reading across the S&P 500, or, for a fall, below the 10th, as measured on 9 November 2026. Each part uses only the company's own filings.
The full analysis
What do Embecta's filings show?
These are Embecta's figures from its filings. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
How much revenue did EMBC have in FY2025?
Embecta had revenue of $1.1B and net income of $95M in fiscal FY2025, a net margin of 8.8%.
How much debt does EMBC have?
On September 30, 2025 Embecta had total assets of $1.1B, debt of $1.4B and shareholders' equity of -$651M.
How much free cash flow does EMBC have?
In fiscal FY2025 Embecta had cash from operations of $192M and spent $9.3M on capital expenditure, leaving $182M of free cash flow.
Where are the figures from?
From Embecta Corp.'s annual and quarterly reports to the SEC, read from the structured data (XBRL) it files itself.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.